Use of Animal Models for Investigating Cardioprotective Roles of SGLT2 Inhibitors
<p dir="ltr">Sodium-glucose co-transporter 2 (SGLT2) inhibitors represent one type of new-generation type 2 diabetes (T2DM) drug treatment. The mechanism of action of an SGLT2 inhibitor (SGLT2i) in treating T2DM depends on lowering blood glucose levels effectively via increasing the...
Saved in:
| Main Author: | Najlaa A. Al Thani (17788493) (author) |
|---|---|
| Other Authors: | Maram Hasan (6672440) (author), Huseyin C. Yalcin (6695099) (author) |
| Published: |
2023
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hemorrhagic ascites as a complication of heart failure: A case report and review of the literature
by: Shahem Abbarh (17945564)
Published: (2022) -
Implications of the medication regimen complexity index score on hospital readmissions in elderly patients with heart failure: a retrospective cohort study
by: Asmaa Abdelbary (16400059)
Published: (2023) -
Chronic anemia complicated by cardiac failure, pulmonary hypertension, and pericardial effusion: a case report
by: Muhammad Yousaf (754345)
Published: (2023) -
“Double-Lumen Valve-Controlled Intra-Operative Pyeloplasty Stent (VIPs)”: A New Technology for Post-Pyeloplasty Stenting – Proof of Concept Study in a Preclinical Large Animal Model
by: Tariq Osman Abbas (18148378)
Published: (2020) -
Diabetes-related cardiovascular and economic burden in patients hospitalized for heart failure in the US: a recent temporal trend analysis from the National Inpatient Sample
by: Menatalla Mekhaimar (14103708)
Published: (2020)